Invention Grant
US08143241B2 DNA damage repair inhibitors for treatment of cancer 有权
DNA损伤修复抑制剂治疗癌症

DNA damage repair inhibitors for treatment of cancer
Abstract:
The present invention relates to the recognition that inhibition of the base excision repair pathway is selectively lethal in cells which are deficient in HR dependent DNA DSB repair. Methods and means relating to the treatment of cancers which are deficient in HR dependent DNA DSB repair using inhibitors which target base excision repair components, such as PARP, is provided herein.
Public/Granted literature
Information query
Patent Agency Ranking
0/0